Search Results - "Tierce, Jonothan C."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis by Murimi-Worstell, Irene B, Lin, Dora H, Nab, Henk, Kan, Hong J, Onasanya, Oluwadamilola, Tierce, Jonothan C, Wang, Xia, Desta, Barnabas, Alexander, G Caleb, Hammond, Edward R

    Published in BMJ open (21-05-2020)
    “…ObjectiveAt least half of patients with systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease or long-term therapeutic…”
    Get full text
    Journal Article
  2. 2

    The Value of U.S. Pharmacopeial Standards: A Review of the Literature by Heyward, James, Padula, William, Tierce, Jonothan C, Alexander, G Caleb

    Published in Journal of pharmaceutical sciences (01-10-2018)
    “…While there are many standard-setting health care organizations, the United States Pharmacopeial Convention's (USP) role includes the creation of documentary…”
    Get more information
    Journal Article
  3. 3

    Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers by Heyward, James, Jones, Christopher M, Compton, Wilson M, Lin, Dora H, Losby, Jan L, Murimi, Irene B, Baldwin, Grant T, Ballreich, Jeromie M, Thomas, David A, Bicket, Mark C, Porter, Linda, Tierce, Jonothan C, Alexander, G Caleb

    Published in JAMA network open (05-10-2018)
    “…Despite epidemic rates of addiction and death from prescription opioids in the United States, suggesting the importance of providing alternatives to opioids in…”
    Get full text
    Journal Article
  4. 4

    Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review by Lin, Dora H, Murimi-Worstell, Irene B, Kan, Hong, Tierce, Jonothan C, Wang, Xia, Nab, Henk, Desta, Barnabas, Hammond, Edward R, Alexander, G Caleb

    Published in Lupus (01-06-2022)
    “…Objectives To evaluate health care utilization and costs for patients with systemic lupus erythematosus (SLE) by disease severity. Methods We searched PubMed…”
    Get full text
    Journal Article
  5. 5

    Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis by Joish, Vijay N, Shah, Sandip, Tierce, Jonothan C, Patel, Deep, McKee, Chad, Lapuerta, Pablo, Zacks, Jerome

    Published in Future oncology (London, England) (01-04-2019)
    “…Elevated serotonin in patients with neuroendocrine tumors (NETs) may impact heart failure incidence but a quantitative relationship has not been established…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus by Munakata, Julie, Benner, Joshua S., Becker, Stephen, Dezii, Christopher M., Hazard, Elisabeth H., Tierce, Jonothan C.

    Published in Medical care (01-10-2006)
    “…Background: Nonadherence with highly active antiretroviral therapy (HAART) is common in typical human immunodeficiency virus (HIV) patient care settings, but…”
    Get full text
    Journal Article
  8. 8

    Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy by Benner, Joshua S, Tierce, Jonothan C, Ballantyne, Christie M, Prasad, Cheryl, Bullano, Michael F, Willey, Vincent J, Erbey, John, Sugano, David S

    Published in PharmacoEconomics (01-01-2004)
    “…The National Cholesterol Education Program recommends regular physician follow-up and lipid testing to promote adherence with lipid-lowering medications. The…”
    Get full text
    Journal Article
  9. 9

    Cost-Effectiveness of Rosuvastatin Compared with Other Statins from a Managed Care Perspective by Benner, Joshua S., Smith, Timothy W., Klingman, David, Tierce, Jonothan C., Mullins, C. Daniel, Pethick, Ned, O'Donnell, John C.

    Published in Value in health (01-11-2005)
    “…The objective of this study was to identify the most cost-effective statin or combination of statins, from the perspective of a managed care payer. A…”
    Get full text
    Journal Article
  10. 10

    Predictors of adherence with antihypertensive and lipid-lowering therapy by Chapman, Richard H, Benner, Joshua S, Petrilla, Allison A, Tierce, Jonothan C, Collins, S Robert, Battleman, David S, Schwartz, J Sanford

    Published in Archives of internal medicine (1960) (23-05-2005)
    “…Patients with comorbid hypertension and dyslipidemia are at high risk for cardiovascular disease, which can be considerably mitigated by treatment. Adherence…”
    Get more information
    Journal Article
  11. 11

    Assessing resource use in oncology patients: a comparison of analyses based on claims data and medical chart review by Semroc, Georgette N, Tierce, Jonothan C, Fridman, Moshe

    Published in Journal of managed care pharmacy (01-03-2003)
    “…Provider claims data are used to make medical analyses and decisions, but such databases typically lack important clinical information. To compare the patterns…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols by GABLE, C. B, TIERCE, J. C, SIMISON, D, WARD, D, MOTTE, K

    “…We report treatment protocols for HIV+/AIDS patients by CD4+ counts (T-lymphocyte cells/mm3: > or = 500, 499-200, 199-50, and < 50) as a tool to provide better…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18